Bayer, J&J's blood pill shows mass-market promise
A new stroke prevention drug developed by Bayer and Johnson & Johnson proved a safe alternative to the standard treatment, lifting their chances of entering a $12 billion plus market, the German drug company said.
View full post on Yahoo! Health News
Bayer, Blood, J&J's, massmarket, pill, promise, shows